Association Between Colitis and Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
Tunio, Nahel A. [1 ]
Cooper, Gregory S. [1 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000590048.19557.62
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
129
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 50 条
  • [1] Association between Myocarditis and Other Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)
    Tashtish, Nour
    Lang, Kate
    Al-Kindi, Sadeer
    Elamm, Chantal
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S63 - S63
  • [2] Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
    Esen, Bugra Han
    Ozbek, Lasin
    Oguz, Sinem
    Selcukbiricik, Fatih
    HELIYON, 2024, 10 (13)
  • [3] Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhou, Chaozheng
    Peng, Shengkun
    Lin, Anqi
    Jiang, Aimin
    Peng, Yuanxi
    Gu, Tianqi
    Liu, Zaoqu
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    ECLINICALMEDICINE, 2023, 59
  • [4] Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Ma, Zhuo
    Pei, Jie
    Sun, Ximu
    Liu, Lihong
    Lu, Wenchao
    Guo, Qixiang
    Lyu, Jiayou
    Liu, Yuwei
    Zhang, Yuhui
    Zhao, Zhixia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [6] Exploring immune checkpoint inhibitor-related adverse events in pediatric cancer patients: A pharmacovigilance analysis of VigiBase and the FDA adverse event reporting system (FAERS) database
    Shen, Junyi
    Lin, Anqi
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    CANCER RESEARCH, 2024, 84 (06)
  • [7] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    HELIYON, 2024, 10 (17)
  • [8] Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
    Tong, Lihua
    Yuan, Yanling
    He, Wanming
    Yang, Wen
    Pan, Xingxi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [9] Immune Checkpoint Inhibitor-Mediated Myocarditis in the US FDA Adverse Event Reporting System
    Rivera, Manuel
    Fernandes, Gilson
    Knijnik, Leonardo
    Olarte, Neal
    Cohen, Mauricio
    CIRCULATION, 2018, 138
  • [10] Immune checkpoint inhibitor-induced acquired haemophilia: A pharmacovigilance analysis of the FDA adverse event reporting system
    Moore, Donald C.
    Elmes, Joseph B.
    Arnall, Justin R.
    Strassels, Scott A.
    Patel, Jai N.
    HAEMOPHILIA, 2022, 28 (05) : E145 - E148
12345